2015
DOI: 10.1007/s13277-015-4205-5
|View full text |Cite
|
Sign up to set email alerts
|

CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases

Abstract: CD20 expression is absent in a variety of diffuse large B cell lymphomas (DLBCLs), including plasmablastic lymphoma, primary effusion lymphoma, anaplastic lymphoma, kinase-positive DLBCL, and large B cell lymphoma arising in human herpesvirus 8-associated multicentric Castleman disease. These rare and heterogeneous tumors are characterized by the presence of proliferating immunoblasts with similar transcriptional profiles as those of plasma cells and are typically associated with highly aggressive pathologies,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
39
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(39 citation statements)
references
References 63 publications
0
39
0
Order By: Relevance
“…[15][16][17][18] Rare cases with Napsin A expression have also been described. The cells are typically CD30 nonreactive (negative); although, focal areas of positivity for CD30, CD79a, and AE1/3 have been reported.…”
Section: Discussionmentioning
confidence: 99%
“…[15][16][17][18] Rare cases with Napsin A expression have also been described. The cells are typically CD30 nonreactive (negative); although, focal areas of positivity for CD30, CD79a, and AE1/3 have been reported.…”
Section: Discussionmentioning
confidence: 99%
“…CD30 was found to be variably positive in 81% of PTLD/DLBCL [7] and in about 14% of immunocompetent patients with DLBCL [8]. CD30 expression is reported to be associated with a favorable outcome in PTLD/DLBCL, regardless of EBV status [7].…”
Section: Discussionmentioning
confidence: 98%
“…This may be particularly important for cytopathologists given that immunohistochemical studies often have a faster turnaround time than [38][39][40][41] Rare cases with Napsin A expression have also been described. Therefore, immunohistochemical studies may be important to perform in these cases in addition to in situ hybridization testing.…”
Section: R Esu L Tsmentioning
confidence: 99%